🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the efficacy and safety of Human coronavirus immune plasma (HCIP)...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-06-03
Trial ID
NCT04373460
Treatments Being Tested
Convalescent plasma has been shown to be safe and effective for treatment o...
Status
Completed
Location
Department of Infectious Disease, Falu Hospital
Start Date
2020-12-03
Trial ID
NCT04649879
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of the admin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-10
Trial ID
NCT04467151
Treatments Being Tested
This is Phase 2 multi-center controlled randomized study to assess the effi...
Status
Completed
Location
NRC Institute of Immunology FMBA
Start Date
2021-04-27
Trial ID
NCT05184127
Treatments Being Tested
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Status
Recruiting
Location
University of Florida
Start Date
2016-04-11
Trial ID
NCT02735707
Treatments Being Tested
In early December 2019, cases of pneumonia of unknown origin were identifie...
Status
Completed
Location
Hospital Universitario José E. Gonzalez
Start Date
2020-04-27
Trial ID
NCT04358783
Treatments Being Tested
Convalescent plasma therapy has been recognized as safe and plasma transfus...
Status
Unknown
Location
Universitätsspital Basel
Start Date
2021-04-08
Trial ID
NCT04836260
Treatments Being Tested
This study is to gain critical knowledge to understand the factors influenc...
Status
Completed
Location
Viollier AG
Start Date
2020-04-09
Trial ID
NCT04351503
This is a prospective, randomized (1:1), double blind study of Convalescent...
Status
Completed
Location
Germans Trias i Pujol Hospital
Start Date
2020-11-10
Trial ID
NCT04621123
Treatments Being Tested
Objectives Primary objectives To assess the superiority or not of the infus...
Status
Terminated
Location
Hospital Galdakao-Usansolo
Start Date
2020-03-31
Trial ID
NCT05247307
Treatments Being Tested